477535-41-4

Usage

Uses

Used in Chemical Synthesis:
3-BROMO-5-(TRIFLUOROMETHYL)BENZALDEHYDE is used as a reagent or intermediate for the preparation of more complex chemical structures. Its unique functional groups allow it to participate in a variety of chemical reactions, making it a valuable component in the synthesis of advanced compounds.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 3-BROMO-5-(TRIFLUOROMETHYL)BENZALDEHYDE is used as a key building block in the development of new drugs. Its presence in the molecular structure can influence the pharmacological properties of the final product, such as potency, selectivity, and bioavailability.
Used in Material Science:
3-BROMO-5-(TRIFLUOROMETHYL)BENZALDEHYDE is employed in the field of material science for the synthesis of novel materials with specific properties. Its incorporation into polymers or other materials can lead to the creation of materials with enhanced characteristics, such as improved thermal stability, chemical resistance, or electrical conductivity.
Used in Research and Development:
In research and development settings, 3-BROMO-5-(TRIFLUOROMETHYL)BENZALDEHYDE is utilized as a starting material for exploring new chemical reactions and pathways. Its reactivity and functional groups make it an interesting candidate for studying reaction mechanisms and developing new synthetic strategies.

InChI:InChI=1/C8H4BrF3O/c9-7-2-5(4-13)1-6(3-7)8(10,11)12/h1-4H

Upstream product

• 172023-97-1 (3‐bromo‐5‐(trifluoromethyl)phenyl)methanol 
• 626-41-5 3,5-dibromophenol 
• 68-12-2 N,N-dimethyl-formamide 
• 401-84-3 1,3-dibromo-5-(trifluoromethyl)benzene 
• 958258-15-6 3-bromo-5-(trifluoromethyl)benzoyl chloride 
• 880652-44-8 3-bromo-N-methoxy-N-methyl-5-(trifluoromethyl)benzamide 
• 328-67-6 3-bromo-5-(trifluoromethyl)benzoic acid 

Downstream Products

• 1229245-04-8 3-[(1E)-3-methoxyprop-1-en-1-yl]-5-(trifluoromethyl)benzaldehyde 
• 1237535-89-5 1-[3-bromo-5-(trifluoromethyl)phenyl]-N,N-dimethylmethanamine 
• 1257310-68-1 (3-formyl-5-trifluoromethylphenyl)carbamic acid 2-trimethylsilanylethyl ester 
• 1274816-90-8 N-[(2R)-7-((2-[(cyclopropylcarbonyl)amino]pyridin-4-yl)oxy)-1,2,3,4-tetrahydronaphthalen-2-yl]-3-[(dimethylamino)methyl]-5-(trifluoromethyl)benzamide 
• 1274817-11-6 N-[(2S)-7-((2-[(cyclopropylcarbonyl)amino]pyridin-4-yl)oxy)-1,2,3,4-tetrahydronaphthalen-2-yl]-3-[(dimethylamino)methyl]-5-(trifluoromethyl)benzamide hydrochloride 
• 1237535-90-8 3-[(dimethylamino)methyl]-5-(trifluoromethyl)benzoic acid lithium salt 
• 1350750-66-1 3-((dimethylamino)methyl)-5-(trifluoromethyl)benzoic acid hydrochloride 
• 154259-25-3 1-[3-bromo-5-(trifluoromethyl)phenyl]ethanone 
• 954124-06-2 1-[3-bromo-5-(trifluoromethyl)phenyl]ethanol 
• 1379375-50-4 3-[(dimethylamino)methyl]-5-(trifluoromethyl)benzaldehyde 
• 172023-97-1 (3‐bromo‐5‐(trifluoromethyl)phenyl)methanol 

Relevant academic research and scientific papers

GLUCOSE-SENSITIVE ALBUMIN-BINDING DERIVATIVES

This invention relates to glucose-sensitive albumin-binding diboron conjugates. More particularly the invention provides novel diboron compounds, and in particular diboronate or diboroxole compounds, useful as intermediate compounds for the synthesis of diboron conjugates. The diboron compounds are characterized by formula (I), which is: R1-X-R2, and wherein "X" is a mono- to multiatomic linker and where R1 and R2, which may be identical or different, each represents a group of Formula (lla) or (IIb) Also described are diboron conjugates represented by the general Formula (I'), which is: R1'-X'-R2', in which either the moeities R1' or R2' or X' carry a drug that is covalently attached to the diboron compound.

NOVEL NEUROKININ 1 RECEPTOR ANTAGONIST COMPOUNDS

The present invention relates to a compound according to formula (A) wherein n is 1 or 2; R1 and R2 are independently hydrogen, C1-4 alkyl, C1-4 haloalkyl, C1-4 alkoxy, CD3 or halogen; R3 is hydrogen, C(=O)OR7 or C1-4 alkyl optionally substituted with hyd

DERIVATIVES OF N-ACYL-N'-PHENYLPIPERAZINE USEFUL (INTER ALIA) FOR THE PROPHYLAXIS OR TREATMENT OF DIABETES

The present invention relates to a compound represented by the formula wherein each symbol is as defined in the present specification, which has a superior RBP4-lowering action and is useful as a pharmaceutical composition for the prophylaxis or treatment of a disease or condition mediated by an increase in RBP4.

3, 4 - SUBSTITUTED PIPERIDINE DERIVATIVES AS RENIN INHIBITORS

The present invention relates to 3,4-substituted piperidinyl - based renin inhibitor compounds bearing at 4-position lsoqumolone and having the Formula (I) : The invention further relates to pharmaceutical compositions containing said compounds, as well a

CETP INHIBITORS

Compounds of Formula (I), including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis. In the compounds of Formu